SCHEMBL4444112

SCHEMBL4444112

Cc1ccc(-c2cc(CCC(=O)NCCN3CCCCC3)nc(C#N)n2)cc1C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSK P43235 9/20 0.53
KCNH2 Q12809 5/20 0.47
CTSS P25774 3/20 0.47
CTSB P07858 1/20 0.47
BCHE P06276 1/20 0.41
ACHE P22303 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
TSHR P16473 1/20 0.41
CYP2C19 P33261 1/20 0.41
IKBKB O14920 2/20 0.41
SCN9A Q15858 1/20 0.40
ATM Q13315 1/20 0.39
IGF1R P08069 1/20 0.39
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 1/20 0.39
POLB P06746 1/20 0.39
GAA P10253 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4444117 0.77 CTSK (0.56) CTSKKCNH2CTSSCTSB
Trifluoromethanesulfonic Acid SCHEMBL4556637 0.75 CTSK (0.47) CTSKKCNH2CTSSCTSBMEN1
Hydrochloric Acid SCHEMBL4440670 0.73 CTSK (0.54) CTSKKCNH2CTSSCTSBKDM4E
SCHEMBL4440054 0.73 CTSK (0.58) CTSKKCNH2CTSSCTSBCYP3A4
SCHEMBL4444486 0.71 CTSK (0.58) CTSKKCNH2CTSSCTSBCYP3A4
SCHEMBL4444488 0.71 CTSK (1.00) CTSKCTSS
SCHEMBL4442745 0.70 CTSK (0.74) CTSKKCNH2CTSSCTSB
SCHEMBL4445908 0.70 CTSK (0.66) CTSKKCNH2CTSSCTSBCYP3A4
Hydrochloric Acid SCHEMBL4454367 0.70 CTSK (0.48) CTSKKCNH2CTSSCTSBBCHE
SCHEMBL4442710 0.69 CTSK (0.72) CTSKCTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7589095-B2 4-phenyl-pyrimidine-2-carbonitrile derivatives N.V. ORGANON (NL) 2009-09-15 US disclosed
EP-1758870-B1 4-PHENYL-PYRIMIDINE-2-CARBONITRILE DERIVATIVES ORGANON NV (NL) 2008-08-13 EP disclosed
US-20080090813-A1 4-Phenyl-Pyrimidine-2-Carbonitrile Derivatives Cai, Jiaqiang 2008-04-17 US disclosed
EP-1758870-A1 4-PHENYL-PYRIMIDINE-2-CARBONITRILE DERIVATIVES N.V. Organon (NL) 2007-03-07 EP disclosed
WO-2005121106-A1 4-PHENYL-PYRIMIDINE-2-CARBONITRILE DERIVATIVES N.V. ORGANON (NL) 2005-12-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080090813-A1 4-Phenyl-Pyrimidine-2-Carbonitrile Derivatives P2RY4, P2RX4, P2RY1 CTSK 1852/4885KCNH2 2293/4885CTSS 2645/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.